-+ 0.00%
-+ 0.00%
-+ 0.00%

Actinium Pharmaceuticals Unveils Potent Preclinical Results for ATNM-400 Targeted Radiotherapy in Breast Cancer Models

Reuters·12/12/2025 13:45:37

Please log in to view news